These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9892378)

  • 21. The importance of hypoalbuminemia in peritoneal dialysis patients: Impact of gender.
    Sikorska D; Olewicz-Gawlik A; Baum E; Pawlaczyk K; Oko A
    Adv Clin Exp Med; 2019 Jun; 28(6):729-735. PubMed ID: 30106520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of albumin concentration in hemodialysis patients.
    Kaysen GA; Stevenson FT; Depner TA
    Am J Kidney Dis; 1997 May; 29(5):658-68. PubMed ID: 9159298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin turnover in renal disease.
    Kaysen GA
    Miner Electrolyte Metab; 1998; 24(1):55-63. PubMed ID: 9397418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.
    Yeun JY; Kaysen GA
    Am J Kidney Dis; 1997 Dec; 30(6):923-7. PubMed ID: 9398142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthropometric measures, cytokines and survival in haemodialysis patients.
    Kimmel PL; Chawla LS; Amarasinghe A; Peterson RA; Weihs KL; Simmens SJ; Alleyne S; Burke HB; Cruz I; Veis JH
    Nephrol Dial Transplant; 2003 Feb; 18(2):326-32. PubMed ID: 12543888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients.
    Ross EA; Shah GM; Kashyap ML
    Int J Artif Organs; 1995 Dec; 18(12):751-6. PubMed ID: 8964640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.
    Perez L; You Z; Teitelbaum I; Andrews ES; Reddin R; Ramirez-Renteria L; Wilson G; Kendrick J
    BMC Nephrol; 2022 Jul; 23(1):245. PubMed ID: 35810296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin Turnover in Peritoneal and Hemodialysis.
    Rippe B; Öberg CM
    Semin Dial; 2016 Nov; 29(6):458-462. PubMed ID: 27525385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammation and nutritional status in haemodialysis patients].
    Tirmenstajn-Janković B; Dimković N; Zivanović M
    Med Pregl; 2007; 60 Suppl 2():137-41. PubMed ID: 18928180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD.
    Cooper BA; Penne EL; Bartlett LH; Pollock CA
    Am J Kidney Dis; 2004 Jan; 43(1):61-6. PubMed ID: 14712428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure.
    Prinsen BH; Rabelink TJ; Beutler JJ; Kaysen GA; De Boer J; Boer WH; Hagen EC; Berger R; De Sain-Van Der Velden MG
    Kidney Int; 2003 Oct; 64(4):1495-504. PubMed ID: 12969171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.
    Yeun JY; Levine RA; Mantadilok V; Kaysen GA
    Am J Kidney Dis; 2000 Mar; 35(3):469-76. PubMed ID: 10692273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dose megestrol increases serum albumin in malnourished dialysis patients.
    Lien YH; Ruffenach SJ
    Int J Artif Organs; 1996 Mar; 19(3):147-50. PubMed ID: 8675357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients.
    Koo HM; Do HM; Kim EJ; Lee MJ; Shin DH; Kim SJ; Oh HJ; Yoo DE; Kim JK; Park JT; Han SH; Kang SW; Choi KH; Yoo TH
    Atherosclerosis; 2011 Dec; 219(2):925-30. PubMed ID: 22015178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
    Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
    Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia.
    Eustace JA; Coresh J; Kutchey C; Te PL; Gimenez LF; Scheel PJ; Walser M
    Kidney Int; 2000 Jun; 57(6):2527-38. PubMed ID: 10844622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of nutritional status between peritoneal dialysis and hemodialysis patients.
    Park YK
    Perit Dial Int; 1999; 19 Suppl 2():S523-6. PubMed ID: 10406578
    [No Abstract]   [Full Text] [Related]  

  • 39. Is serum albumin a marker of nutritional status in hemodialysis patients without evidence of inflammation?
    Santos NS; Draibe SA; Kamimura MA; Canziani ME; Cendoroglo M; Júnior AG; Cuppari L
    Artif Organs; 2003 Aug; 27(8):681-6. PubMed ID: 12911340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study.
    Kalantar-Zadeh K; Braglia A; Chow J; Kwon O; Kuwae N; Colman S; Cockram DB; Kopple JD
    J Ren Nutr; 2005 Jul; 15(3):318-31. PubMed ID: 16007562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.